3M CO (MMM) Overview
Healthcare • NYSE • CIK 0000066740
Loading...
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
Market Cap
$96.37B
P/E (TTM)
27.3x
Rev Growth (TTM)
+1.7%
Net Margin (TTM)
14.0%
FCF Yield (TTM)
2.8%
FCF Margin (TTM)
10.6%
Figures as of September 30, 2026
Filings
Primary-source SEC disclosures, read end-to-end. SEC figures cite the filing they come from.
8-KNov 20262026-11-03source
10-Q2026 Q32026-10-20source
8-KEarnings2026-10-20source
8-KOct 20262026-10-19source
8-KSep 20262026-09-10source
What your agent reads
Investor Relations
Company-published material — management’s own words, not SEC-audited. Each source below is labeled so your agent knows what to verify.
Company-published, not SEC-audited
Earnings
Q3
27 days ago
8-K releaseRevenue
$6.58B
+1.0%
Net Income
$1.41B
—
EPS
N/A
—
Most recent quarterly earnings snapshot
Cash Flow Health
Free Cash Flow6/8 positive
TTM$2.7B
Q3 '26
$230.0M-70%
Q2 '26
$763.0M+119%
FCF Margin
TTM10.6%
Q3 '263.5%-70%
Sector: 3.3%Above Avg
OCF Margin
14.4%
OCF/NI1.03x
CapEx Coverage
3.8x
FCF Yield2.8%
FCF Growth (3Y)-18%
Cash Conversion Cycle
76 days
DSO: 55+DIO: 90−DPO: 69
Cash flow trends & capital efficiency
Capital Allocation
Total Shareholder YieldTTM
TTM5.6%
Div Yield1.6%
+Buyback (TTM)3.9%
Dividend & Payout Metrics
Dividend Yield (TTM)1.6%
FCF Payout Ratio58.9%
Free Cash Flow (TTM)$2.7B
Stock Repurchases (TTM)$3.8B
Capital Return / FCF201.0%
Shares Outstanding (YoY)-2.7%↓ Buyback
Est. Dividends Paid (TTM)$1.6B
Shows how management rewards shareholders
Valuation Metrics
Price-to-EarningsTTM
27.3x
Volatile
8Q: 24.3x-175%
High PEG ratio (4.0x) suggests expensive for growth
Valuation Lenses
Earnings
27.3x
vs – sector
Cash Flow
39.7x
EV/FCF vs –
Growth-Adj
4.0xPEG
Expensive for growth
Quality-Adj
1.5P/E per %ROIC
ROIC: 18.6%
Shareholder Returns
Dividend
1.6%
Buyback
3.9%
Total Yield
5.6%
Market Cap$96.37B
EV$106.22B
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
Multi-angle valuation analysis with sector context
Margins & Efficiency
ROIC 75th pctile
Profitability Cascade
Gross
39.5%
Operating
18.8%
Top 25% in sector
Net
14.0%
Margins Unknown
Return on Invested CapitalTTM
18.6%
Stable
+0.0% YoY8Q: 19.3%+3.2%
P25MedianP75
75th pctl (med: -8.0%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
15.2%
8Q: 16.6%
Asset Turnover
0.69x
8Q: 0.66x
Leverage (1+D/E)
4.63x
D/E: 3.63x
DuPont: 48.3% ≈ 18.6% ROIC
Asset & CapEx Efficiency
Fixed Asset Turn
3.60x
8Q:3.44x
+54.4%
Invested Cap Turn
1.23x
8Q:1.18x
+16.8%
CapEx Intensity
4.6%
8Q:4.5%
CapEx/Depreciation
0.67x
FCF vs Net Margin Gap-3.4 pts
Margin trends, ROIC, and capital efficiency
Balance Sheet & Solvency
ND/EBITDA 1.4x
Net Debt / EBITDA
1.4xNet Debt: $9.85B
Interest Coverage
5.5x
+Strong interest coverage: 5.5x
Leverage Metrics
Debt-to-Equity
3.63x
Balance sheet risk & solvency analysis
Related Research
2 related posts